Symposia & Initiatives

Gender, Health, and Diabetes Symposium Summary

SPEAKERS

PDF version


Gender, Health, and Diabetes Symposium Summary

Panelist Biographies


Professor Moshe Hod

Professor Moshe Hod is Director of the Maternal Fetal Medicine Division at the Helen Schneider Women's Hospital, Rabin Medical Center and Professor of Obstetrics and Gynecology at the Sackler Faculty of Medicine, Tel-Aviv University, Israel.

Moshe Hod serves as a member of the Executive Board of European Association of Perinatal Medicine (EAPM) and as the Chairman of the Working Group on Diabetes and Pregnancy of EAPM. Moshe Hod was the Chairman of the Board of the Diabetic Pregnancy Study Group (DPSG) of the European Association for the Study of Diabetes (EASD) and of the postgraduate educational committee of the EASD. Prof. Hod is a Member of the Steering Committee and Regional Director of the Hyperglycemia and Adverse Pregnancy Outcome (HAPO), a National Institutes of Health (NIH) funded study.

Prof. Hod served as the Chairman of the Medical Advisory Board and Medical Director of Global Medical Networks (GMN) developers of a technology to build patient-centric eHealth Networks (LifeOnKey®). Prof. Hod currently serves as the Chairman of the Medical Advisory Board of Rosetta Genomics (NASDAQ:ROSG), leader in the development of microRNA-based diagnostics and therapeutics.

Moshe Hod is the editor of the recently published second edition of the TEXTBOOK OF DIABETES AND PREGNANCY, Publishers: Informa Healthcare, London, UK as well as the author of more then 200 scientific publications.

Prof. Hod has organized and chaired 15 international congresses and given workshops on various aspects of perinatal medicine.


Saralyn Mark, MD

Saralyn Mark, MD, an endocrinologist, geriatrician and women's health specialist, was the first Senior Medical Advisor to the Office on Women's Health within the Department of Health and Human Services and the National Aeronautics and Space Administration (NASA) for ten years. As Senior Medical Advisor, Dr. Mark was responsible for the development and analysis of initiatives and programs on emerging technologies, public health preparedness, physician workforce issues, sex and gender based medicine and women's health on earth and in space.

As a pioneer in women's health, she designed the first women's health fellowship in the Nation, helped create the National Centers of Leadership in Academic Medicine, the National Centers of Excellence in Women's Health in academic and community health centers across the country and landmark educational campaigns on critical health issues. Dr. Mark is now President of SolaMed Solutions, LLC. In this capacity, she serves as a medical and scientific policy advisor to organizations and agencies including NASA and the Cook Group.

Dr. Mark is a Diplomate of the National Board of Medical Examiners and had been the civilian representative to the Surgeon General Physician Advisory Committee. She has chaired or served on over 50 national and international editorial and advisory boards, commissions and task forces including the President's Interagency Council on Women, the National Institutes of Health Federal Work Group on Bone Diseases, the NASA Medical Policy Board, NCQA HEDIS Measurement Advisory Panel, and the United Nations Global Commission on Women's Health.

Dr. Mark is an Associate Professor adjunct at the Yale University School of Medicine in the Departments of Medicine and Obstetrics and Gynecology as well as at the Georgetown University School of Medicine. Dr. Mark is also an Affiliate Professor and Distinguished Senior Fellow in the School of Public Policy at George Mason University. She is an alumna of the New York University School of Medicine and Barnard College of Columbia University and completed her residency, fellowships and first academic appointment at the University of California at San Francisco School of Medicine (UCSF). At UCSF, Dr. Mark conducted clinical research trials in osteoporosis, lipids and cardiovascular disease. Dr. Mark continues to foster the development of innovative programs and policies which affect the lives of men and women around the world.


Dr. Gojka Roglic

Dr. Gojka Roglic is medical officer responsible for the WHO diabetes programme within the Department of Chronic Diseases and Health Promotion, based in Geneva, Switzerland. Dr Roglic has received training as physician and epidemiologist at the University of Zagreb, Croatia and the London School of Hygiene and Tropical Medicine, London, UK.

Dr. Roglic worked as a diabetologist and epidemiologist at the University Clinic for Diabetes, Endocrinology and Metabolic Diseases in Zagreb, Croatia.

Dr. Roglic participated in many national surveys of diabetes epidemiology and several large international studies and trials in the field of diabetes . (WHO Multinational Study of Vascular Disease in Diabetes - Mortality follow-up, WHO DIAMOND IDDM Incidence Study, EURODIAB IDDM Complications Study, EURODIAB IDDM Prospective Complications Study, EURODIAB IDDM Family Nephropathy Study, EURODIAB IDDM Incidence Study, EUCLID Study, Da Qing Follow-up study).

Dr. Roglic took up her current post at WHO in 1999 and is responsible for global estimates of diabetes prevalence and mortality, as well as for guidelines for diabetes screening, diagnosis, classification and management.


Dr. Anuraj Shankar

Dr. Anuraj H. Shankar, D.Sc. is the Coordinator for Monitoring and Evaluation in the Department of Making Pregnancy Safer at WHO, Geneva. After serving as a Peace Corps volunteer in Mauritania, West Africa he completed his doctoral degree in immunology at Harvard University in 1993 and began a career aimed at integrating basic science, public health, and human development. Dr. Shankar brings a unique perspective based on a diverse knowledge base and over 25 years of international experience.

He has served on the faculty of The Johns Hopkins Bloomberg School of Public Health since 1993, and worked with Helen Keller International as Regional Advisor-Asia/Pacific and Director of Biomedical Sciences and Programmatic Research in Indonesia. He has conducted large scale field research and advised on program activities in multiple countries in Asia, Latin America, and Africa, and has authored nearly 50 articles on immunology, infectious disease, nutrition, and maternal and infant health.

Dr. Shankar has served on multiple expert panels for WHO and UNICEF and is a core contributor to global health initiatives such as the Countdown 2015, the Global Alliance for Prevention of Prematurity and Stillbirths, and is a founding member of the Quality of Care for Pregnancy and Childbirth (QCPC) Collaborative. His recent work in Indonesia established an operational paradigm for large scale community participation in design and execution of research and use of data locally to enhance maternal and perinatal health programs.

Dr. Shankar's current areas of interest at WHO relate to integration of health interventions and monitoring to build local capacity for use of data in decision-making to scale up services and strengthen quality of care to reduce maternal and perinatal deaths.


Elaine M. Wolfson, Ph.D.

Elaine M. Wolfson, Ph.D. is Founding President of the Global Alliance for Women's Health (GAWH), a non-governmental organization (NGO) with consultative status with the United Nations Economic and Social Council. Since its formation GAWH has been a leader in advocating, developing and articulating policy for improving women's health in all stages of life throughout the world.

A cornerstone of GAWH's work has been to develop public/private partnerships that advance an understanding of all aspects of women's health throughout the life cycle, and to articulate the implications of this knowledge for public policy and development at the international and country levels.

GAWH has partnered with more than 35 member states and their permanent missions in New York, Geneva and Addis Ababa. It has also developed partnerships with foundations, universities, UN agencies as well as a cross-section of international and national NGOs and private sector corporations in order to present symposia, organize and facilitate caucuses and develop international networks at UN world meetings, such as the World Summit for Social Development, Copenhagen; the Fourth World Conference on Women, Beijing; and the World Health Organization's (WHO) Jakarta meeting for health promotion. GAWH also reviews bio-medical and epidemiological research on women's health issues. Its analysis of trachoma as a women's health issue and the consequent implications for international public health policy has been cited by the London School of Hygiene and the Carter Center.

Elaine Wolfson has been a consultant to UN agencies such as WHO and INSTRAW. Her publications on women's health include monographs, articles and edited compilations. She has taught graduate courses in political science and public policy at New York University; the State University of New York (SUNY), Stony Brook; the City University of New York (CUNY), Baruch; and Rutgers University, Newark. She was educated at Smith College (BA), New York University (MA and Ph.D.) and the Wharton School of the University of Pennsylvania (certificate).